Wolverine Asset Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-32,360
Closed -$2K 2775
2022
Q2
$2K Buy
+32,360
New +$5.62K ﹤0.01% 2267

Other funds holding FLACW

Wolverine Asset Management's FLACW Position: Q3 2022 in Review

Wolverine Asset Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 32,360 shares — an estimated $2K sold.

Wolverine Asset Management first reported a position in FLACW in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

  • Wolverine Asset Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 32,360 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $2K.
  • Wolverine Asset Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2022 and held it in 1 quarter.
  • Wolverine Asset Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $2K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.